Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
about
Metabolic impact of anti-angiogenic agents on U87 glioma cellsExpression Profile of Genes Related to Drug Metabolism in Human Brain TumorsVascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis.Phase II study of sunitinib malate in patients with recurrent high-grade glioma.A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.Selection of suitable reference genes for quantitative real-time polymerase chain reaction in human meningiomas and arachnoideaDynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models.Diffusion MR Imaging of the Brain in Patients with CancerSignificance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.Phase II study of single-agent bevacizumab in Japanese patients with recurrent malignant glioma.Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model.Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab.Targeted therapy for malignant glioma patients: lessons learned and the road ahead.Canine astrocytic tumors: a comparative review.Evolution of care for patients with relapsed glioblastoma.Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy.Expression of stem cell marker and receptor kinase genes in glioblastoma tissue quantified by real-time RT-PCRSplicing factor hnRNPH drives an oncogenic splicing switch in gliomasDownregulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo.Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment.Tyrosine phosphorylation modulates the vascular responses of mesenteric arteries from human colorectal tumors.Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors.Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab.Association between genetic variations of vascular endothelial growth factor receptor 2 and glioma in the Chinese Han population.Single-agent bevacizumab is an effective treatment in recurrent glioblastoma.Focal neurons: another source of vascular endothelial growth factor in brain arteriovenous malformation tissues?Histopathological vascular investigation of the peritumoral brain zone of glioblastomas.Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma.Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells.VEGFR2 expression and TGF-β signaling in initial and recurrent high-grade human glioma.Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications.
P2860
Q28539644-33251F3C-5C95-4A97-A2EF-46F0AA703A50Q28551028-EC0165C5-4415-4AAF-A347-0DEBDAD8B136Q30934034-936BF870-0C4D-4B87-A4F2-C824D46F36A2Q33392046-67BEC3E4-CFFE-46CC-975C-789BFB2507F8Q33428049-1DBF02DC-9A77-40A5-96BE-97C9F3C502BBQ33977752-4257161E-C3C6-4D18-A834-F0CBF0E4B911Q34480549-E9F5A96F-1A62-4E9F-ADFF-19C1F530097FQ35450291-591A962B-3921-4E91-93B2-DAFD569A7451Q35954103-EB04BFDC-ED0E-4841-8CEA-79C699D4A804Q36251337-8AEAED75-84A4-49E6-9466-D2DCA2B0FF05Q37354846-5F60C616-9F7F-450B-802D-C17D01DCA179Q37395361-3F9D99BB-6DB5-4860-BF9C-2182E78C5409Q37533648-C49E6921-D472-4450-870B-18179631AB12Q37808081-A65C6709-8B3B-4732-812F-40948A755B2EQ37952240-55E5807A-F1A9-4934-982D-8C10AE8B1173Q38599484-E98A417B-DF54-4282-B759-830602952839Q38752082-DFD9C339-1684-4791-B5F9-B69B7013C6ABQ38967517-6EA28493-4083-4D45-9F17-0358E51E733CQ40279860-AB1A6703-363B-4E42-8E9E-56F0D74DE7B4Q41314113-0CC19197-03C9-411B-A2D0-8025BB55EA07Q41857963-B376183F-1399-45B9-A2DC-5D6EE1A4517EQ42864506-0C64681A-E391-4079-9626-2DC57789941AQ44756866-9EEF7ABD-B919-4344-8367-EC72B344A4D9Q45990804-68B58DBA-E81B-42D8-9B13-2E5C910B55D6Q46498971-7264460B-CA47-4E84-9736-25CA850169C2Q47231193-1DBF7BD6-E39B-4282-A683-EAE0D8ED3DEEQ47832964-84919644-9FBE-4D97-BB9D-9D7C7E646D82Q47942210-9763E810-F28C-42FF-88FE-BB8C2D0CAFC9Q47943313-37C453CA-27FE-4267-B305-27F77C5CD46EQ48383330-D9201C4B-043E-4FDE-9B8B-509CF032B666Q48669602-5ABBD4F0-816A-4005-BFFC-D804ACA1C067Q48853324-8DB06F5F-DFE8-464D-B878-9999A79B341FQ55388033-2D85602F-134B-4165-A7B8-8A970E943A15
P2860
Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
@en
Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
@nl
type
label
Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
@en
Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
@nl
prefLabel
Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
@en
Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
@nl
P2860
P356
P1476
Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
@en
P2093
P2860
P304
P356
10.1179/016164105X39833
P577
2005-07-01T00:00:00Z